SPINAL FLUID CHANGES IN PATIENTS TREATED WITH ATARACTIC DRUGS
Abstract
In a series of 25 patients on ataractic therapy and 25 other mental patients as controls, there was no essential difference in the incidence of increased protein or abnormal gold curves. The high incidence of abnormal findings in both of these groups, however, points to the possibility that these abnormal findings are unspecific and may also be found to a certain extent within the general healthy population. This study does not support the assumption that increased spinal fluid protein and abnormal gold curves are the result of ataractic therapy.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).